Aug 13, 2020
Global Pancreatic and Biliary Stents Market Analysis (2015-2020) and Forecast (2020-2030) Model - Key Trends and Developments Resulting from the COVID-19 Pandemic
Aug 12, 2020
Resoundant Expands Its Research Services Footprint
Jun 22, 2020
Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual Meeting
Jun 22, 2020
twoXAR Pharmaceuticals Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311
Jun 17, 2020
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B
Jun 04, 2020
Protagonist Therapeutics to Present at the 25th European Hematology Association (EHA) Annual Congress
Jun 02, 2020
RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
May 24, 2020
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
May 13, 2020
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
May 11, 2020
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs
May 07, 2020
Protagonist Therapeutics Announces Initial Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera
May 06, 2020
FDA Grants MIV-818 Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma
Apr 30, 2020
Medivir Receives Positive Opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818
Apr 29, 2020
Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention of Veno-Occlusive Disease
Apr 28, 2020
The Global Tumor Ablation Market is expected to grow from USD 473.95 Million in 2018 to USD 1,649.04 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 19.49%
Apr 19, 2020
Innovent Biologics Announces FDA Approval of Pemazyre(TM) (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
Apr 17, 2020
FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts
Apr 03, 2020
Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market
Mar 31, 2020
Bausch Health Announces Favorable Topline Results From Study Evaluating Investigative Formulation of Rifaximin SSD IR to Treat Overt Hepatic Encephalopathy
Mar 24, 2020
Worldwide Tumor Ablation Industry Insights, 2020: Dominated by Medtronic and Johnson & Johnson